Narayana Hrudayalaya Ltd.
NSE: NH | BSE: 539551
₹1,993.20
As on 09-Jul-2026IST
Market cap
₹40,644 Cr
Revenue (TTM)
₹7,896 Cr
P/E Ratio
50.5
P/B Ratio
9
Div. Yield
0.2 %
Quality Score
9/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹806 Cr
-
ROE
24.3 %
-
ROCE
21.6 %
-
Industry P/E
50.16
-
EV/EBITDA
25.3
-
Debt to Equity
1
-
Book Value
₹222
-
EPS
₹41.7
-
Face value
10
-
Shares outstanding
204,360,804
10 Years Aggregate
CFO
₹5,223.90 Cr
EBITDA
₹5,619.59 Cr
Net Profit
₹2,843.72 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Narayana Hrud
| 5.3 | 3.7 | 16.0 | 1.4 | 25.5 | 33.1 | 20.6 |
|
BSE Healthcare
| 14.7 | 6.3 | 18.3 | 11.9 | 24.3 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Narayana Hrud
| 44.2 | 5.8 | 58.1 | 18.9 | 42.3 | 37.5 | 60.8 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Narayana Hrud
|
1,993.2 | 40,644.3 | 7,896.0 | 811.6 | 14.8 | 19.8 | 50.5 | 9.0 |
| 8,845.5 | 1,27,148.1 | 25,228.5 | 1,957.7 | 11.5 | 21.1 | 65.5 | 13.4 | |
| 807.2 | 41,804.6 | 4,643.2 | 464.1 | 13.7 | 8.9 | 107.7 | 9.1 | |
| 485.6 | 15,373.7 | 2,080.1 | 168.1 | 14.1 | 6.7 | 115.4 | 7.6 | |
| 951.5 | 71,834.3 | 9,127.8 | 1,047.8 | 17.9 | 11 | 69 | 7.3 | |
| 652.7 | 9,732.3 | 2,545.4 | 21.3 | 8.7 | 11.4 | 707.3 | 7.3 | |
| 1,464.1 | 9,583.1 | 1,499.8 | 194.2 | 17.1 | 13.4 | 49.4 | 6.2 | |
| 1,101.3 | 1,07,147.7 | 8,373.5 | 1,442.4 | 21.5 | 14.3 | 74.3 | 10.0 | |
| 1,481.5 | 15,028.3 | 1,703.1 | 281.5 | 23.1 | 18.1 | 54 | 9.1 | |
| 820.9 | 7,917.0 | 1,199.2 | 171.1 | 16.3 | 10.2 | 45.1 | 4.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsHow did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
About Narayana Hrud
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood... bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India. Read more
-
Incorporated
2000
-
Chairman
Devi Prasad Shetty
-
Managing Director
Emmanuel Rupert
-
Group
Devi Prasad Shetty
-
Headquarters
Bengaluru, Karnataka
-
Website
Looking for more details about Narayana Hrudayalaya Ltd.’s IPO? Explore our IPO Details page.
Quarterly Updates
Annual Reports
FAQs for Narayana Hrud
What is the current share price of Narayana Hrudayalaya Ltd Today?
The share price of Narayana Hrudayalaya Ltd is ₹1,993.20 (NSE) and ₹1,988.85 (BSE) as of 09-Jul-2026 IST. Narayana Hrudayalaya Ltd has given a return of 25.48% in the last 3 years.
What is the current PB & PE ratio of Narayana Hrudayalaya Ltd?
The P/E ratio of Narayana Hrudayalaya Ltd is 50.45 times as on 09-Jul-2026, a 1 premium to its peers’ median range of 50.16 times.
The P/B ratio of Narayana Hrudayalaya Ltd is 8.96 times as on 09-Jul-2026, a 26 premium to its peers’ median range of 7.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
43.74
|
9.53
|
|
2024
|
33.15
|
9.07
|
|
2023
|
26.08
|
7.42
|
|
2022
|
44.59
|
10.27
|
|
2021
|
0.00
|
7.43
|
What is the 52 Week High and Low of Narayana Hrudayalaya Ltd?
The 52-week high and low of Narayana Hrudayalaya Ltd are Rs 2,093.30 and Rs 1,589.00 as of 09-Jul-2026.
What is the market cap of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd has a market capitalisation of ₹ 40,644 Cr as on 09-Jul-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Narayana Hrudayalaya Ltd?
Before investing in Narayana Hrudayalaya Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
